🇺🇸 FDA
Patent

US 9353175

Use of antagonists targeting metallothionein to treat intestinal inflammation

granted A61KA61K2039/505A61P

Quick answer

US patent 9353175 (Use of antagonists targeting metallothionein to treat intestinal inflammation) held by UNIVERSITY OF CONNECTICUT expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
UNIVERSITY OF CONNECTICUT
Grant date
Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K2039/505, A61P, A61P37/06